⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14034405 | 0.65 | — | — | |
| SCHEMBL12673520 | 0.64 | PLAT (0.32) | — | |
| SCHEMBL10338856 | 0.64 | — | — | |
| SCHEMBL24840924 | 0.58 | — | — | |
| SCHEMBL4572140 | 0.58 | DGAT1 (0.37) | — | |
| SCHEMBL4283523 | 0.58 | DRD2 (0.36) | — | |
| SCHEMBL15061721 | 0.57 | CYP17A1 (0.33) | — | |
| SCHEMBL23176239 | 0.55 | PDE10A (0.33) | — | |
| SCHEMBL22547459 | 0.55 | EGFR (0.36) | — | |
| SCHEMBL3460690 | 0.55 | PIK3CG (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5302712-A | Intermediates for cephem compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-04-12 | — | — | US | disclosed |
| US-5215982-A | Antibiotics | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-01 | — | — | US | disclosed |
| EP-0427248-A2 | New cephem compounds and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-15 | — | — | EP | disclosed |